Drugs / Cytokine-induced killer cells (CIK)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02497898 | Jul 2015 → Jul 2038 expected | non-Hodgkin lymphoma | The First People's Hospital of Changzhou | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cytokine-induced killer cells (CIK) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02497898 ↗ |
| Modality | Cell therapy | “Autologous cytokine-induced killer (CIK) cells transfusion” NCT02497898 ↗ |